Literature DB >> 2592899

Risk factors for breast cancer by mode of diagnosis: some results from a breast cancer screening study.

J Whitehead1, J Cooper.   

Abstract

We have investigated factors affecting the probability that a woman with breast cancer participating in a mammographic screening programme will be diagnosed by the screen. Data from a large American case-control study, with subjects drawn from women participating in an annual screening programme, were used. During the screening programme, 409 cases were identified, the mode of diagnosis being screen detection for 331 and interval detection for 78. No significant relationships were found between mode of diagnosis and age, age at menarche, oral contraceptive use, age at first live birth, age at menopause or history of maternal breast cancer. There was a non-significant trend for particular mammographic patterns to be associated with interval detection. However relative risk of breast cancer and probability of interval detection were observed to increase about the time of the menopause. These results suggest that the 3 yearly mammography programme being introduced in the UK might be improved if an extra examination was included around the time of the menopause.

Entities:  

Mesh:

Year:  1989        PMID: 2592899      PMCID: PMC1052812          DOI: 10.1136/jech.43.2.115

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  8 in total

1.  Ovulatory failure in a normal population and in patients with breast cancer.

Authors:  M C Swain; R D Bulbrook; J L Hayward
Journal:  J Obstet Gynaecol Br Commonw       Date:  1974-08

Review 2.  The menopause and breast cancer.

Authors:  F E Alexander; M M Roberts
Journal:  J Epidemiol Community Health       Date:  1987-06       Impact factor: 3.710

3.  Breast Cancer Detection Demonstration Project: five-year summary report.

Authors:  L H Baker
Journal:  CA Cancer J Clin       Date:  1982 Jul-Aug       Impact factor: 508.702

4.  Breast cancer prediction and the Wolfe classification of mammograms.

Authors:  T Carlile; K J Kopecky; D J Thompson; J R Whitehead; F I Gilbert; A J Present; B A Threatt; P Krook; E Hadaway
Journal:  JAMA       Date:  1985 Aug 23-30       Impact factor: 56.272

Review 5.  A different perspective on breast cancer risk factors: some implications of the nonattributable risk.

Authors:  H Seidman; S D Stellman; M H Mushinski
Journal:  CA Cancer J Clin       Date:  1982 Sep-Oct       Impact factor: 508.702

6.  Breast patterns as an index of risk for developing breast cancer.

Authors:  J N Wolfe
Journal:  AJR Am J Roentgenol       Date:  1976-06       Impact factor: 3.959

7.  The relationship between Wolfe's classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer.

Authors:  J Whitehead; T Carlile; K J Kopecky; D J Thompson; F I Gilbert; A J Present; B A Threatt; P Krook; E Hadaway
Journal:  Am J Epidemiol       Date:  1985-12       Impact factor: 4.897

8.  Wolfe mammographic parenchymal patterns. A study of the masking hypothesis of Egan and Mosteller.

Authors:  J Whitehead; T Carlile; K J Kopecky; D J Thompson; F I Gilbert; A J Present; B A Threatt; P Krook; E Hadaway
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

  8 in total
  3 in total

1.  Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.

Authors:  C T Brekelmans; P Westers; J A Faber; P H Peeters; H J Collette
Journal:  J Epidemiol Community Health       Date:  1996-02       Impact factor: 3.710

2.  Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.

Authors:  C H van Gils; J D Otten; A L Verbeek; J H Hendriks; R Holland
Journal:  J Epidemiol Community Health       Date:  1998-04       Impact factor: 3.710

3.  The epidemiological profile of women with an interval cancer in the DOM screening programme.

Authors:  C T Brekelmans; P H Peeters; J A Faber; J J Deurenberg; H J Collette
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.